The Week in Review: September 1 – September 8, 2017

Friday, September 8, 2017 News Recap: She thought her mystery ailment was cancer, but bloodwork revealed a surprise This is an amazing story ...but it could happen to anyone, and we know this because we hear these kinds of stories often. This is why it is so important that Boomers be tested for hepatitis C. Gail Wells got really sick and nobody could figure out why. They looked for cancer, for multiple sclerosis, for vitamin deficiencies, and then s...

Sharing injection paraphernalia does not lead to HCV transmission

New findings suggest that sharing paraphernalia used to cook and prepare injection drugs does not directly lead to transmission of hepatitis C virus. According to Robert Heimer, PhD, professor of epidemiology and pharmacology at the Yale School of Public Health, and colleagues, this contrasts with past epidemiological studies that reported HCV incidence linked to sharing “cookers” and filters. Heimer said those studies were not clear on whether the result

Injection drug users at four times higher risk of Hep C than HIV: UNODC

There are about 12 million people in the world who inject drugs, of which 6.1 million have contracted Hep C while 1.6 million suffer from AIDS and 1.3 million users suffer from both diseases. Three times more people who use drugs die from Hepatitis C (222,000) than from HIV (60,000), a new United Nations Office on Drugs and Crime report found. Injection drug users (IDUs) are also at four times higher risk of contracting Hepatitis C than AIDS, the repor

The Week in Review: May 12, 2017 – May 19, 2017

Friday, May 19, 2017 News Recap Canada Help4Hep – BC Helpline Now Online: Did you know that there is now a British Columbia toll-free hepatitis C peer-to-peer helpline where you can get accurate information and meaningful help that is free of charge and confidential?  Check it out now! Help4Hep – BC Helpline Now Online URGENT! Patient and Caregiver Input Request: We Need to Hear your Voice! Patient and Caregiver input is requested by CADTH on Abb...

Hepatitis C Virus Reinfection is Uncommon for Those on Opiate Substitution Therapy after Being Cured with DAAs

Most people on opiate substitution therapy were successfully treated for hepatitis C with an interferon-free regimen of grazoprevir/elbasvir (Zepatier), and only a small number became reinfected during three years of follow-up, researchers reported yesterday at the 25th International Harm Reduction Conference (HR17) in Montréal. Hepatitis C virus (HCV) is easily transmitted through shared drug injection equipment. The advent of new direct-acting antiviral

Incidence, Risk factors and Prevention of Hepatitis C Reinfection

MedicalResearch.com Interview with: Naveed Zafar Janjua, MBBS, MSc, DrPH, Senior Scientist, Clinical Prevention Services BC Centre for Disease Control Clinical Associate Professor, School of Population and Public Health, University of British Columbia MedicalResearch.com: What is the background for this study? Response: Hepatitis C is a viral infection that affects the liver. About quarter of people infected with hepatitis C clear their infection spo

Breakdown of Hepatitis C Genotype Distribution Around the World

People who inject drugs (PWID) are more likely to develop hepatitis C. The Centers for Disease Control and Prevention (CDC) points out that the virus can survive on equipment, such as needles, for up to three weeks. However, some of the different hepatitis C genotypes are more prominent in certain areas than others. A report published in the Journal of Hepatology uncovered the distribution of hepatitis C genotypes by continent in PWID. Geert Robaeys, MD,

Could hepatitis C treatments help prevent virus transmission?

University of Bristol An international team of researchers has shed light on the potential impact of new drugs for hepatitis C virus (HCV). HCV is an important cause of liver cancer and is transmitted through blood to blood contact. People who inject drugs (PWID) and men who have sex with men (MSM), who are also infected with HIV, are key risk groups for HCV infection in UK. New HCV treatments are highly effective, with cure rates often better t...

AIDS expert to head $5-million research efforts on hepatitis C

The provincial government is spending $5 million to study ways to reduce the spread of hepatitis C among intravenous drug users located mainly on Vancouver’s Downtown Eastside. Health Minister Terry Lake made the announcement Thursday in Vancouver with the director of  the BC Centre for Excellence in HIV/AIDS, Dr. Julio Montaner, who will lead the research. Montaner championed the ‘treatment as prevention’ approach to HIV/AIDS in which everyone diagnosed

Devising a Strategy to Control the HCV Epidemic in British Columbia, Canada

CROIConference Dates and Location: February 22–25, 2016 | Boston, MassachusettsAbstract Number: 533Devising a Strategy to Control the HCV Epidemic in British Columbia, CanadaAuthor(s): Ignacio Rozada1; Julio Montaner2; Mark W. Hull2; Viviane D. Lima2 1British Columbia Cntr for Excellence in HIV/AIDS, Vancouver, BC, Canada;2BC Cntr for Excellence in HIV/AIDS, Vancouver, BC, CanadaAbstract Body: In 2012, less than 1% of the estimated 12,000 hepatitis C (HCV)